Article3 Biotech2021
Development of a defined medium for
Article in 3 Biotech, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Acetate-containing supernatants from industrial off-gas cultivation enabling high-value product formation with established and emerging production organisms.Biotechnology for biofuels and bioproducts · 2026Article
- Regulatory Machinery of Bacterial Bioflocculant Synthesis and Optimisation and Assessment of Bioflocculation Efficiency in Wastewater.International journal of molecular sciences · 2025Article
- Industrial Microbial Technologies for Feed Protein Production from Non-Protein Nitrogen.Microorganisms · 2025Review
- A screening setup to streamlineMaterials today. Bio · 2025Article
- Enabling and improvingFrontiers in bioengineering and biotechnology · 2025Article
- Response surface-based media optimization for astaxanthin production inFrontiers in bioengineering and biotechnology · 2025Article
- Combination of Two-Stage Continuous Feeding and Optimized Synthetic Medium Increases Lipid Production inEngineering in life sciences · 2025Article
- Multivariate modular metabolic engineering and medium optimization for vitamin BSynthetic and systems biotechnology · 2024Article
- Review of the Proteomics and Metabolic Properties ofMicroorganisms · 2024Review
- Sustainable production of 2,3,5,6-Tetramethylpyrazine at high titer in engineered Corynebacterium glutamicum.Journal of industrial microbiology & biotechnology · 2024Article
- Development of chemically defined media for3 Biotech · 2023Article
- Current advances for omics-guided process optimization of microbial manufacturing.Bioresources and bioprocessing · 2023Review
- Glucosylation of Isoeugenol and Monoterpenes inMolecules (Basel, Switzerland) · 2023Article
- Sweat and Sebum Preferences of the Human Skin Microbiota.Microbiology spectrum · 2023Article
- Genome-scale metabolic models consistently predictFrontiers in bioinformatics · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-021-02959-6.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.